Literature DB >> 9154287

The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.

P D Imesch1, I H Wallow, D M Albert.   

Abstract

Iris color can be affected by a variety of ocular disorders. It is suspected that iris color may not remain constant throughout life. These observations have drawn attention to the morphologic correlates of iris color and its regulation. Differences in the iris color of normal eyes are the result of variable amounts of melanin pigment granules within a constant number of melanocytes in the superficial stroma of the iris. These melanocytes seem to reach their genetically determined amount of melanin in early childhood, and their melanin content usually remains constant in adulthood. Diseases such as Horner's syndrome and Fuchs' heterochromic iridocyclitis affect iris color, resulting in a decrease of iris pigmentation. Evidence suggests that melanin content of some melanocytes is subject to adrenergic regulation even past childhood. Application of the prostaglandin analogue latanoprost, on the other hand, leads to an increase in iris pigmentation in some patients. Studies with cultured dermal and uveal melanocytes, as well as with uveal melanoma cells, however, show no increase in cell proliferation when treated with latanoprost in vitro. The mechanisms by which latanoprost affects regulation of iris pigmentation requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154287     DOI: 10.1016/s0039-6257(97)80018-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  24 in total

1.  Tooth, skin, hair and eye colour interrelationships in Greek young adults.

Authors:  Panagiotis E Lagouvardos; Ioana Tsamali; Christine Papadopoulou; Gregory Polyzois
Journal:  Odontology       Date:  2012-02-19       Impact factor: 2.634

Review 2.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

3.  A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation.

Authors:  David L Duffy; Grant W Montgomery; Wei Chen; Zhen Zhen Zhao; Lien Le; Michael R James; Nicholas K Hayward; Nicholas G Martin; Richard A Sturm
Journal:  Am J Hum Genet       Date:  2006-12-20       Impact factor: 11.025

4.  Defining a comprehensive verotype using electronic health records for personalized medicine.

Authors:  Mary Regina Boland; George Hripcsak; Yufeng Shen; Wendy K Chung; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2013-09-03       Impact factor: 4.497

5.  Horner's, Heterochromia, and Harlequins.

Authors:  Avital Y O'Glasser; Kresimira M Milas
Journal:  J Gen Intern Med       Date:  2015-04-02       Impact factor: 5.128

Review 6.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

7.  Iris color and visual functions.

Authors:  Christian Nischler; Ralph Michael; Christine Wintersteller; Patrick Marvan; Laurentius J van Rijn; Joris E Coppens; Thomas J T P van den Berg; Martin Emesz; Günther Grabner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 3.117

8.  A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.

Authors:  Daniel M Albert; Ronald E Gangnon; Hans E Grossniklaus; W Richard Green; Soesiawati Darjatmoko; Amol D Kulkarni
Journal:  Arch Ophthalmol       Date:  2008-05

9.  Multilocus OCA2 genotypes specify human iris colors.

Authors:  Tony Frudakis; Timothy Terravainen; Matthew Thomas
Journal:  Hum Genet       Date:  2007-07-07       Impact factor: 4.132

Review 10.  Latanoprost : an update of its use in glaucoma and ocular hypertension.

Authors:  Caroline M Perry; Jane K McGavin; Christine R Culy; Tim Ibbotson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.